Search

Eric A Grovender

from Wayzata, MN
Age ~50

Eric Grovender Phones & Addresses

  • 6412 Landings Ct, Excelsior, MN 55331 (952) 401-1745
  • Wayzata, MN
  • Chanhassen, MN
  • 1728 Knox Ave S, Minneapolis, MN 55403 (617) 254-1457
  • 8249 Newton Ave N, Minneapolis, MN 55444
  • Brooklyn Park, MN
  • Malibu, CA
  • Woodbury, MN
  • Santa Monica, CA
  • Los Angeles, CA

Publications

Us Patents

Long Term Analyte Sensor Array

View page
US Patent:
8523773, Sep 3, 2013
Filed:
Jul 15, 2009
Appl. No.:
12/503753
Inventors:
Rajiv Shah - Rancho Palos Verdes CA, US
Rebecca K. Gottlieb - Culver City CA, US
Eric A. Grovender - Minneapolis MN, US
Shaun M. Pendo - Wofford Heights CA, US
Paul Citron - New Brighton MN, US
William P. Van Antwerp - Valencia CA, US
Assignee:
Medtronic MiniMed, Inc. - Northridge CA
International Classification:
A61B 5/00
US Classification:
600365, 600345, 600347
Abstract:
A long term analyte sensor for measuring at least one analyte in the body of a user and which includes a housing, a plurality of analyte contacting sensor elements and at least one structure for relaying information away from the sensor. This plurality of analyte contacting sensor elements are typically disposed in an array. The analyte sensor further includes at least one sensor protection membrane that is controllable in a manner such that sensor elements may be activated (e. g. exposed to the external environment) at different times so as to extend the useful life of the sensor. In illustrative analyte sensors, the analyte is glucose.

Osmotic Pump Apparatus And Associated Methods

View page
US Patent:
20080102119, May 1, 2008
Filed:
Nov 1, 2006
Appl. No.:
11/591374
Inventors:
Eric A. Grovender - Malibu CA, US
Ashok V. Joshi - Salt Lake City UT, US
John Howard Gordon - Salt Lake City UT, US
Sai Bhavaraju - West Jordan UT, US
William P. Van Antwerp - Valencia CA, US
International Classification:
A61K 9/24
A61K 9/22
US Classification:
424473, 6048901
Abstract:
Apparatuses and methods for pumping fluids such as fluid medications are disclosed. Embodiments of the invention provide an osmotic pump fluid delivery apparatus including elements designed to control the fluid delivery rate. Typical embodiments of the invention include an arrangement of elements such as solute reservoirs that can manipulate the solute concentrations within an inner osmotic compartment or compartments of an osmotic pump so as to control fluid delivery from the pump. Other embodiments include sealed electro-osmotic pumps that do not discharge ions into the surroundings or require water from an external source. These embodiments of the invention provide new ways to control fluid delivery in apparatuses that employ osmotic processes to function.

Osmotic Pump Apparatus And Associated Methods

View page
US Patent:
20090281528, Nov 12, 2009
Filed:
May 12, 2009
Appl. No.:
12/464722
Inventors:
Eric A. Grovender - Minneapolis MN, US
John H. Gordon - Salt Lake City UT, US
William P. Van Antwerp - Valencia CA, US
Assignee:
MEDTRONIC, INC. - Minneapolis MN
International Classification:
A61K 9/22
US Classification:
6048921
Abstract:
Apparatuses and methods for pumping fluids such as fluid medications are disclosed. In illustrative embodiments of the invention, the architectural geometry of one or more fluid containing chambers within a fluid delivery device is constructed to incorporate design parameters that function to control movement of fluids within the device. Typical embodiments of the invention provide osmotic pumps that use such elements to control various fluid delivery parameters.

Angiogenesis Mechanism And Method, And Implantable Device

View page
US Patent:
20100196439, Aug 5, 2010
Filed:
Dec 20, 2007
Appl. No.:
12/520035
Inventors:
Michael Theodore Beck - Eden Prairie MN, US
Deon Bezuidenhout - Cape Town, ZA
Kelvin Bonnema - Brooklyn Park MN, US
Kimberly A. Chaffin - Woodbury MN, US
Neil Davies - Vredehoek, ZA
Brian C.A. Fernandes - Roseville MN, US
Eric J. Fogt - Maple Grove MN, US
Eric A. Grovender - Minneapolis MN, US
Robert Cushing Hamlen - Edina MN, US
Matthew Jolly - Minneapolis MN, US
Eamonn J. McAndrew - County Galway, IE
Syamasundar V. Pakala - Blaine MN, US
William P. VanAntwerp - Valencia CA, US
Peter P. Zilla - Cape Town, ZA
Edouard A. Koullick - Golden Valley MN, US
Assignee:
Medtronic, Inc. - Minneapolis MN
International Classification:
A61K 9/00
A61K 38/18
A61K 35/12
A61P 3/10
US Classification:
424424, 514 12, 424 931
Abstract:
Various methods and devices are provided for providing therapy to a living body. In one embodiment, an implanted permeable container has living cells provided therein, and various nutrients and/or agents are provided into the container to promote cell life.

Biosensors And Methods For Making And Using Them

View page
US Patent:
20100279377, Nov 4, 2010
Filed:
May 20, 2010
Appl. No.:
12/784233
Inventors:
Rajiv Shah - Rancho Palos Verdes CA, US
Gopikrishnan Soundararajan - Irvine CA, US
Rebecca K. Gottlieb - Culver City CA, US
Udo Hoss - Sherman Oaks CA, US
Eric A. Grovender - Minneapolis MN, US
Shaun M. Pendo - Wofford Heights CA, US
Assignee:
MEDTRONIC MINIMED, INC. - Northridge CA
International Classification:
C12N 11/08
US Classification:
435180
Abstract:
Embodiments of the invention provide analyte sensors having optimized permselective membranes and methods for making and using such sensors. Embodiments of the invention also provide analyte sensors such as those having porous matrices coated with an analyte sensing composition and methods for making and using such sensors. Illustrative embodiments include electrochemical glucose sensors having glucose oxidase coatings.

Biosensors And Methods For Making And Using Them

View page
US Patent:
20100280347, Nov 4, 2010
Filed:
May 20, 2010
Appl. No.:
12/784220
Inventors:
Rajiv Shah - Rancho Palos Verdes CA, US
Gopikrishnan Soundararajan - Irvine CA, US
Rebecca K. Gottlieb - Culver City CA, US
Udo Hoss - Sherman Oaks CA, US
Eric A. Grovender - Minneapolis MN, US
Shaun M. Pendo - Wofford Heights CA, US
Assignee:
MEDTRONIC MINIMED, INC. - Northridge CA
International Classification:
A61B 5/1473
B65D 71/00
G01N 27/26
G01N 27/30
US Classification:
600347, 600345, 206569, 204279, 204284
Abstract:
Embodiments of the invention provide analyte sensors having optimized permselective membranes and methods for making and using such sensors. Embodiments of the invention also provide analyte sensors such as those having porous matrices coated with an analyte sensing composition and methods for making and using such sensors. Illustrative embodiments include electrochemical glucose sensors having glucose oxidase coatings.

Continuous Subcutaneous Administration Of Interferon-Alpha To Hepatitis C Infected Patients

View page
US Patent:
20110027229, Feb 3, 2011
Filed:
Aug 2, 2010
Appl. No.:
12/848856
Inventors:
William P. Van Antwerp - Valencia CA, US
Eric A. Grovender - Minneapolis MN, US
Harry L. A. Janssen - Rotterdam, NL
Robert J. De Knegt - Rotterdam, NL
Assignee:
MEDTRONIC, INC. - Minneapolis MN
International Classification:
A61K 38/21
C07K 14/52
A61P 31/14
A61M 5/142
US Classification:
424 857, 530351, 604151, 604 66
Abstract:
Methods and systems for treating Hepatitis C infections are provided. Typically the method comprises administering interferon-α to the patient subcutaneously using a continuous infusion apparatus, wherein this therapeutic regimen is sufficient to maintain circulating levels of interferon-α in the serum of the patient above a target concentration for a certain period of time.

Method And System To Define Patient Specific Therapeutic Regimens By Means Of Pharmacokinetic And Pharmacodynamic Tools

View page
US Patent:
20110184379, Jul 28, 2011
Filed:
Mar 27, 2009
Appl. No.:
12/934054
Inventors:
William P. Van Antwerp - Valencia CA, US
Robert C. Hamlen - Edina MN, US
Eric A. Grovender - Minneapolis MN, US
Assignee:
MEDTRONIC, INC. - Minneapolis MN
International Classification:
A61M 5/168
A61K 38/21
A61K 31/7056
A61P 31/14
US Classification:
604503, 424 857, 514 43, 604 66
Abstract:
Methods for treating Hepatitis infections are provided. In one embodiment, an initial dosage of interferon is administered to a patient, and interferon serum levels and viral load data is collected over time. This data can be used to determine patient-specific pharmacokinetic and pharmacodynamic parameters and then construct patient-specific interferon delivery profiles. Patient-specific delivery profiles can then be used to design patient-specific therapeutic regimens.
Eric A Grovender from Wayzata, MN, age ~50 Get Report